NUVL insider transaction filings
Nuvalent, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen NUVL transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner Deerfield Mgmt IV, L.P. — Director, 10% owner Deerfield Private Design Fund IV, L.P. — Director, 10% owner | Disposition to issuer (D): 8,299,225 @ $124 · Disposition to issuer (D): 8,299,225 @ $124 · Disposition to issuer (D): 650,000 @ $124 · Code (U): 5,146 @ $124 · Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 @ $124 · +12 more | EDGAR |
| 2026-07-15 | 4 | Balcom Alexandra — Chief Financial Officer | Code (U): 44,433 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 131,637 (derivative) · Disposition to issuer (D): 8,016 (derivative) · +5 more | EDGAR |
| 2026-07-15 | 4 | Turner Christopher Durant — Chief Medical Officer | Code (U): 31,530 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 303,105 (derivative) · Disposition to issuer (D): 2,835 (derivative) · +5 more | EDGAR |
| 2026-07-15 | 4 | Noci Darlene — Chief Development Officer | Code (U): 17,017 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 216 (derivative) · Disposition to issuer (D): 6,091 (derivative) · +6 more | EDGAR |
| 2026-07-15 | 4 | Lane Benjamin — See Remarks | Code (U): 21,092 @ $124 · Disposition to issuer (D): 29,433 · Grant/award (A): 7,120 @ $0 · Disposition to issuer (D): 7,120 · Disposition to issuer (D): 731 (derivative) · Disposition to issuer (D): 8,333 (derivative) · +5 more | EDGAR |
| 2026-07-15 | 4 | Pelish Henry E. — Chief Scientific Officer | Code (U): 22,393 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 3,258 (derivative) · Disposition to issuer (D): 2,113 (derivative) · +6 more | EDGAR |
| 2026-07-15 | 4 | Porter James Richard — President and CEO, Director | Code (U): 203,529 @ $124 · Disposition to issuer (D): 121,350 · Grant/award (A): 40,025 @ $0 · Disposition to issuer (D): 40,025 · Disposition to issuer (D): 508,942 (derivative) · Disposition to issuer (D): 49,401 (derivative) · +7 more | EDGAR |
| 2026-07-15 | 4 | Miller Deborah Ann — Chief Legal Officer | Code (U): 18,534 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 72,608 (derivative) · Disposition to issuer (D): 61,000 (derivative) · +4 more | EDGAR |
| 2026-07-15 | 4 | Oliger Christy J. — Director | Code (U): 1,324 @ $124 · Disposition to issuer (D): 6,091 · Disposition to issuer (D): 6,119 (derivative) | EDGAR |
| 2026-07-15 | 4 | Wheeler Cameron — Director | Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 · Disposition to issuer (D): 43,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 3,789 (derivative) · +1 more | EDGAR |
| 2026-07-15 | 4 | Meyers Michael L. — Director | Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 · Disposition to issuer (D): 8,361 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 3,789 (derivative) · +1 more | EDGAR |
| 2026-07-15 | 4 | Bogle Grant C. — Director | Code (U): 3,714 @ $124 · Disposition to issuer (D): 5,577 · Disposition to issuer (D): 4,851 (derivative) · Disposition to issuer (D): 4,147 (derivative) | EDGAR |
| 2026-07-15 | 4 | Srivastava Sapna — Director | Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 · Disposition to issuer (D): 68,500 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 3,789 (derivative) · +1 more | EDGAR |
| 2026-07-15 | 4 | Squarer Ron — Director | Disposition to issuer (D): 6,281 · Disposition to issuer (D): 4,418 (derivative) | EDGAR |
| 2026-07-15 | 4 | Protopapas Anna — Director | Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 3,789 (derivative) · +1 more | EDGAR |
| 2026-07-10 | 4 | Pelish Henry E. — Chief Scientific Officer | Sale (S): 2,111 @ $123.81 | EDGAR |
| 2026-07-08 | 4 | Porter James Richard — President and CEO, Director | Option exercise (M): 30,000 @ $18.93 · Sale (S): 30,000 @ $123.72 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 9,146 @ $18.93 · Option exercise (M): 13,854 @ $72.35 · Sale (S): 23,000 @ $123.59 · Option exercise (M): 9,146 (derivative) @ $0 · Option exercise (M): 13,854 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Balcom Alexandra — Chief Financial Officer | Option exercise (M): 5,384 @ $6.89 · Option exercise (M): 6,046 @ $18.93 · Sale (S): 11,430 @ $123.58 · Option exercise (M): 5,384 (derivative) @ $0 · Option exercise (M): 6,046 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 5,500 @ $123.51 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Oliger Christy J. — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Wheeler Cameron — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Meyers Michael L. — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Bogle Grant C. — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Srivastava Sapna — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Squarer Ron — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Protopapas Anna — Director | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-18 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-11 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 10,000 @ $1.08 · Option exercise (M): 685 @ $6.89 · Option exercise (M): 9,315 @ $18.93 · Sale (S): 20,000 @ $122.81 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 685 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-10 | 4 | Porter James Richard — President and CEO, Director | Option exercise (M): 30,000 @ $18.93 · Sale (S): 12,495 @ $87.97 · Sale (S): 14,469 @ $88.79 · Sale (S): 3,036 @ $89.63 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Balcom Alexandra — Chief Financial Officer | Option exercise (M): 11,430 @ $6.89 · Sale (S): 960 @ $94.87 · Sale (S): 2,170 @ $95.99 · Sale (S): 900 @ $97.68 · Sale (S): 1,200 @ $98.57 · Sale (S): 3,133 @ $99.86 · +4 more | EDGAR |
| 2026-06-01 | 4 | Miller Deborah Ann — Chief Legal Officer | Option exercise (M): 5,500 @ $6.89 · Sale (S): 1,401 @ $106.32 · Sale (S): 1,530 @ $107.45 · Sale (S): 900 @ $108.14 · Sale (S): 1,669 @ $109.30 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 1,300 @ $106.26 · Sale (S): 1,422 @ $107.33 · Sale (S): 1,178 @ $108.01 · Sale (S): 1,500 @ $109.30 · Sale (S): 100 @ $109.76 · +1 more | EDGAR |
| 2026-05-06 | 4 | Porter James Richard — President and CEO, Director | Option exercise (M): 30,000 @ $18.93 · Sale (S): 1,699 @ $98.54 · Sale (S): 1,408 @ $99.77 · Sale (S): 7,429 @ $101.48 · Sale (S): 17,353 @ $102.10 · Sale (S): 2,111 @ $102.88 · +1 more | EDGAR |
| 2026-05-05 | 4 | Balcom Alexandra — Chief Financial Officer | Option exercise (M): 7,159 @ $1.08 · Option exercise (M): 4,271 @ $6.89 · Sale (S): 3,872 @ $98.42 · Sale (S): 7,434 @ $99.29 · Sale (S): 124 @ $99.97 · Option exercise (M): 7,159 (derivative) @ $0 · +1 more | EDGAR |
| 2026-05-01 | 4 | Miller Deborah Ann — Chief Legal Officer | Option exercise (M): 5,500 @ $6.89 · Sale (S): 4,418 @ $99.13 · Sale (S): 1,082 @ $99.57 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 4,500 @ $99.35 · Sale (S): 700 @ $100.14 · Sale (S): 300 @ $101.17 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-04-13 | 4 | Pelish Henry E. — Chief Scientific Officer | Option exercise (M): 3,093 @ $27.85 · Sale (S): 2,193 @ $104.27 · Sale (S): 900 @ $105 · Option exercise (M): 3,093 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | Porter James Richard — President and CEO, Director | Option exercise (M): 13,714 @ $18.93 · Option exercise (M): 16,286 @ $27.85 · Sale (S): 11,354 @ $103.21 · Sale (S): 12,425 @ $103.78 · Sale (S): 6,121 @ $104.78 · Sale (S): 100 @ $105.60 · +2 more | EDGAR |
| 2026-04-03 | 4 | Balcom Alexandra — Chief Financial Officer | Option exercise (M): 11,430 @ $1.08 · Sale (S): 3,544 @ $104.39 · Sale (S): 5,417 @ $105.30 · Sale (S): 2,469 @ $106.18 · Option exercise (M): 11,430 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Lane Benjamin — See Remarks | Grant/award (A): 9,500 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 2,532 @ $97.43 · Sale (S): 2,968 @ $98.13 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Miller Deborah Ann — Chief Legal Officer | Option exercise (M): 5,500 @ $6.89 · Sale (S): 940 @ $97.50 · Sale (S): 1,757 @ $98.21 · Sale (S): 2,803 @ $99.46 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Balcom Alexandra — Chief Financial Officer | Option exercise (M): 11,430 @ $1.08 · Sale (S): 2,599 @ $95.03 · Sale (S): 7,671 @ $95.88 · Sale (S): 1,160 @ $96.50 · Sale (S): 13,700 @ $100.16 · Option exercise (M): 11,430 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Pelish Henry E. — Chief Scientific Officer | Option exercise (M): 8,456 @ $18.93 · Option exercise (M): 1,754 @ $27.85 · Option exercise (M): 4,125 @ $29.33 · Option exercise (M): 2,985 @ $72.35 · Sale (S): 24,189 @ $97.79 · Sale (S): 5,505 @ $98.44 · +8 more | EDGAR |
| 2026-03-10 | 4 | Porter James Richard — President and CEO, Director | Option exercise (M): 30,000 @ $27.85 · Sale (S): 13,585 @ $98.59 · Sale (S): 16,015 @ $99.29 · Sale (S): 400 @ $100.19 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 3,000 @ $102.64 · Sale (S): 2,300 @ $103.44 · Sale (S): 200 @ $104.25 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Miller Deborah Ann — Chief Legal Officer | Option exercise (M): 5,500 @ $6.89 · Sale (S): 2,698 @ $102.64 · Sale (S): 2,602 @ $103.41 · Sale (S): 200 @ $103.96 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Noci Darlene — Chief Development Officer | Option exercise (M): 5,500 @ $27.85 · Sale (S): 189 @ $100.95 · Sale (S): 3,429 @ $101.80 · Sale (S): 1,819 @ $102.67 · Sale (S): 63 @ $103.39 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Miller Deborah Ann — Chief Legal Officer | Option exercise (M): 700 @ $27.85 · Sale (S): 700 @ $109.84 · Option exercise (M): 14,300 @ $27.85 · Sale (S): 14,300 @ $110.16 · Option exercise (M): 700 (derivative) @ $0 · Option exercise (M): 14,300 (derivative) @ $0 | EDGAR |
Recent 8-K events — Nuvalent, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-15 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-12-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NUVL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →